Association of epileptiform abnormalities and seizures in Alzheimer disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received November 18, 2019
- Accepted in final form May 14, 2020
- First Published August 6, 2020.
Article Versions
- Previous version (August 6, 2020 - 12:44).
- You are viewing the most recent version of this article.
Author Disclosures
- Alice D. Lam, MD, PhD*,
- Rani A. Sarkis, MD, MSc*,
- Kyle R. Pellerin, BS,
- Jin Jing, PhD,
- Barbara A. Dworetzky, MD,
- Daniel B. Hoch, MD,
- Claire S. Jacobs, MD, PhD,
- Jong Woo Lee, MD, PhD,
- Daniel S. Weisholtz, MD,
- Rodrigo Zepeda, MD,
- M. Brandon Westover, MD, PhD,
- Andrew J. Cole, MD and
- Sydney S. Cash, MD, PhD
- Alice D. Lam, MD, PhD*,
NONE
NONE
1) American Clinical Neurophysiology Society, funding for travel (hotel) to speak at annual ACNS 2020 annual meeting
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) Empatica
1) NIH - NINDS - K23 NS101037, PI, 2018-present 2) NIH - NIA - R21 AG064413, PI, 2019-present 3) NIH - NINDS - R25 NS065743, investigator on supplement, 2014-2016
NONE
1) American Academy of Neurology - Susan Spencer Award
NONE
NONE
NONE
NONE
NONE
NONE
- Rani A. Sarkis, MD, MSc*,
NONE
NONE
NONE
Serves on the editorial board of Epilepsy and Behavior.
NONE
NONE
NONE
NONE
NONE
EEG reading for Digitrace
1- Brigham and Woman's Hospital, EEG reading, 30% effort
1- UCB 2- Empatica 3- Biogen
NONE
NONE
1- American Epilepsy Society
NONE
NONE
NONE
NONE
NONE
NONE
- Kyle R. Pellerin, BS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jin Jing, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Barbara A. Dworetzky, MD,
Nonprofit research trial: Chair,DSMB for the The NIH study entitled The established status Epilepticus treatment trial (ESETT) that recently closed.
NONE
non Profit: role as member of the Annals of Neurology Journal and ATN oversight committee, one hotel night paid for at last ANA meeting
Epilepsy Currents, just completed 4 years on editorial board
NONE
I get a very small amount of royalties from Oxford University Press for my book entitled: Psychogenic Nonepileptic Seizures: Toward the Integration of Care, 2017
NONE
Digitrace, Consultant, eeg interpretation, commercial Best Doctors, Clinical Consultant, commercial
NONE
Nonprofit, Professional advisory board for the epilepsy foundation of New England Board of Directors, American Epilepsy Society
NONE
site PI, the padsevonil trials, parexel/UCB
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Daniel B. Hoch, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Claire S. Jacobs, MD, PhD,
NONE
NONE
NONE
NONE
Dr. Jacobs is an inventor on two patents related to the synthesis and use of DNA binding small molecules targeted to transcription factor binding sites: United States Patent US 7,935,530 B2. 2007 Nov 28; United States Patent US 9,630,950. 2017 Apr 25.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NIH/NINDS, R25NS065743, PI, 2017- 2019 (completed June 2019)
(1) Massachusetts General Hospital, Department of Neurology funds
(1) Bluefield Project to Cure FTD, (2) Philanthropic Support for CIC Precision Medicine
NONE
NONE
NONE
NONE
NONE
NONE
- Jong Woo Lee, MD, PhD,
Nonprofit Investigation of silent mesial temporal lobe hyperexcitability in AlzheimerÂs Disease Grant Number: NIA R21AG064413
NONE
NONE
Epilepsy Currents, 2016-now
NONE
NONE
NONE
Soterya Inc.: co-founder, scientific advisor
NONE
(1) Advance Medical; contract work (2) DigiTrace; contract work
NONE
NONE
NIH R01 NS062092; site PI NIH U01 NS098968; site PI
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Daniel S. Weisholtz, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NIMH, 1R21MH107820-01A1, co-investigator, 2018 (2) DARPA, W911NF-14-2-0045, co-investigator, 2018-2019 (3) NASA, NNX16A069A, co-investigator, 2019-2020 (4) NIH, 5R01NS062092-07, co-investigator, 2019-2020 (5) NIH, 5U01NS098968-03, co-investigator, 2019-2020
NONE
NONE
NONE
NONE
NONE
NONE
NONE
CVS, Expert witness for plaintiff.
- Rodrigo Zepeda, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- M. Brandon Westover, MD, PhD,
(1) Scientific advisor for Beacon Biosignals, Inc.
NONE
NONE
NONE
NONE
Pocket Neurology, Lippincott Williams & Wilkins (2010). Pocket Neurology, 2nd Edition, Walters-Kluwer (2016).
NONE
NONE
NONE
NONE
NONE
NONE
NIH (1R01NS102190, 1R01NS102574, 1R01NS107291)
NONE
NONE
(1) Beacon Biosignals, Inc.
NONE
NONE
NONE
NONE
NONE
- Andrew J. Cole, MD and
1. Precisis AG 2. Medtronic 3. Sage Therapeutics
NONE
Neuropace - Travel
Associate Editor, Annals Clinical and Translational Neurology
NONE
UpToDate
NONE
Consultant to Sage Therepeutics, Precisis AG Pfizer Biogen Ovid
NONE
NONE
NONE
Neuropace Stock/Stock Options, Medical Equipment & Materials: Precisis AG, 2013 Sage Pharmaceuticals, 2013
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sydney S. Cash, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Funded as PI from NIH/NINDS R01-NS062092 Stock/Stock Options, Medical Equipment & Materials: Beacon Biosignals, 2019
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (A.D.L., K.R.P., J.J., D.B.H., C.S.J., M.B.W., A.J.C., S.S.C.), Massachusetts General Hospital; Department of Neurology (R.A.S., B.A.D., J.W.L., D.S.W.), Brigham and Women's Hospital, Boston, MA; and Department of Neurology and Neurotherapeutics (R.Z.), UT Southwestern Medical Center, Dallas, TX.
- Correspondence
Dr. Lam Lam.Alice{at}mgh.harvard.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Research
EEG correlates of seizure freedom in genetic generalized epilepsiesUdaya Seneviratne, Ray C. Boston, Mark Cook et al.Neurology: Clinical Practice, November 10, 2016 -
Articles
Electroencephalographic monitoring during hypothermia after pediatric cardiac arrestN. S. Abend, A. Topjian, R. Ichord et al.Neurology, June 01, 2009 -
Article
Criteria for defining interictal epileptiform discharges in EEGA clinical validation studyMustafa Aykut Kural, Lene Duez, Vibeke Sejer Hansen et al.Neurology, April 22, 2020 -
Brief Communications
Epileptiform EEG abnormalities in children with language regressionK. A. McVicar, K. Ballaban-Gil, I. Rapin et al.Neurology, July 11, 2005